77 related articles for article (PubMed ID: 10221514)
21. Genomic DNA amplification and the detection of t(2;5)(p23;q35) in lymphoid neoplasms.
Sarris AH; Luthra R; Cabanillas F; Morris SW; Pugh WC
Leuk Lymphoma; 1998 May; 29(5-6):507-14. PubMed ID: 9643564
[TBL] [Abstract][Full Text] [Related]
22. Low grade malignant non-Hodgkin's lymphomas and peripheral pleomorphic T-cell lymphomas in childhood--a BFM study group report.
Bucsky P; Feller AC; Reiter A; Beck J; Bertram U; Eschenbach C; Gerein V; Lakomek M; Stollmann B; Tausch W
Klin Padiatr; 1990; 202(4):258-61. PubMed ID: 2203939
[TBL] [Abstract][Full Text] [Related]
23. Biological heterogeneity of diffuse mixed small and large cell non-Hodgkin's lymphomas assessed by DNA flow cytometry and Ki67.
Palestro G; Pich A; Chiusa L; Geuna M; Ponti R; Kerim S; Novero D; Valente G
Leuk Lymphoma; 1995 Nov; 19(5-6):467-72. PubMed ID: 8590848
[TBL] [Abstract][Full Text] [Related]
24. Dendritic reticulum cell immunoreactivity for low-affinity nerve growth factor receptor in malignant lymphomas.
Dorfman DM; Shahsafaei A
Mod Pathol; 1996 Oct; 9(10):959-65. PubMed ID: 8902831
[TBL] [Abstract][Full Text] [Related]
25. Expression of TGF beta1 genes and their receptor types I, II, and III in low- and high-grade malignancy non-Hodgkin's lymphomas.
Woszczyk D; Gola J; Jurzak M; Mazurek U; Mykała-Cieśla J; Wilczok T
Med Sci Monit; 2004 Jan; 10(1):CR33-7. PubMed ID: 14704634
[TBL] [Abstract][Full Text] [Related]
26. Frequency of bcl-2 expression in non-Hodgkin's lymphoma: a study of 778 cases with comparison of marginal zone lymphoma and monocytoid B-cell hyperplasia.
Lai R; Arber DA; Chang KL; Wilson CS; Weiss LM
Mod Pathol; 1998 Sep; 11(9):864-9. PubMed ID: 9758366
[TBL] [Abstract][Full Text] [Related]
27. Molecular pathways in low grade B-cell lymphoma.
Gaidano G; Pastore C; Capello D; Cilli V; Saglio G
Leuk Lymphoma; 1997 Dec; 26 Suppl 1():107-13. PubMed ID: 9570687
[TBL] [Abstract][Full Text] [Related]
28. Immunohistochemical evidence of abnormal expression of the antioncogene-encoded p53 phosphoprotein in Hodgkin's disease and CD30+ anaplastic lymphomas.
Doglioni C; Pelosio P; Mombello A; Scarpa A; Chilosi M
Hematol Pathol; 1991; 5(2):67-73. PubMed ID: 1680118
[TBL] [Abstract][Full Text] [Related]
29. Optimization of quantitative real-time RT-PCR parameters for the study of lymphoid malignancies.
Lossos IS; Czerwinski DK; Wechser MA; Levy R
Leukemia; 2003 Apr; 17(4):789-95. PubMed ID: 12682639
[TBL] [Abstract][Full Text] [Related]
30. [Detection and significance of chromosome abnormalities in patients with malignant non-Hodgkin's lymphoma using the polymerase chain reaction].
Janda J; Benesová E; Slavícková A; Klener P
Cas Lek Cesk; 1999 Jan; 138(2):47-51. PubMed ID: 10376403
[TBL] [Abstract][Full Text] [Related]
31. c-Myc oncogene and Cdc25A cell activating phosphatase expression in non-Hodgkin's lymphoma.
Aref S; Fouda M; El-Dosoky E; Menessy A; Mabed M; Saleeb M; Zalata K
Hematology; 2003 Jun; 8(3):183-90. PubMed ID: 12745652
[TBL] [Abstract][Full Text] [Related]
32. DNA polymerase chain reaction using fine needle aspiration biopsy smears to evaluate non-Hodgkin's lymphoma.
Grosso LE; Collins BT
Acta Cytol; 1999; 43(5):837-41. PubMed ID: 10518139
[TBL] [Abstract][Full Text] [Related]
33. Positron emission tomography (PET) for staging low-grade non-Hodgkin's lymphomas (NHL).
Najjar F; Hustinx R; Jerusalem G; Fillet G; Rigo P
Cancer Biother Radiopharm; 2001 Aug; 16(4):297-304. PubMed ID: 11603000
[TBL] [Abstract][Full Text] [Related]
34. Analysis of BCL2 and MYC expression in non-Hodgkin's lymphomas by in situ hybridization: correlation with chromosome translocations.
Murty VV; Ladanyi M; Houldsworth J; Mikraki V; Chaganti RS
Diagn Mol Pathol; 1992 Dec; 1(4):221-8. PubMed ID: 1342969
[TBL] [Abstract][Full Text] [Related]
35. Common features and differences in the transcriptome of large cell anaplastic lymphoma and classical Hodgkin's lymphoma.
Willenbrock K; Küppers R; Renné C; Brune V; Eckerle S; Weidmann E; Bräuninger A; Hansmann ML
Haematologica; 2006 May; 91(5):596-604. PubMed ID: 16670065
[TBL] [Abstract][Full Text] [Related]
36. Activation of MYCN in a case of non-Hodgkin's lymphoma.
Finnegan MC; Hammond DW; Hancock BW; Goyns MH
Leuk Lymphoma; 1995 Aug; 18(5-6):511-4. PubMed ID: 8528061
[TBL] [Abstract][Full Text] [Related]
37. Gene expression profiling of non-hodgkin lymphomas.
Zekri AR; Hassan ZK; Bahnassy AA; Eldahshan DH; El-Rouby MN; Kamel MM; Hafez MM
Asian Pac J Cancer Prev; 2013; 14(7):4393-8. PubMed ID: 23992009
[TBL] [Abstract][Full Text] [Related]
38. MDR-1 expression in non-Hodgkin's lymphomas is unrelated to treatment intensity or response to therapy.
Finnegan MC; Royds J; Goepel JR; Lorigan P; Hancock BW; Goyns MH
Leuk Lymphoma; 1995 Jul; 18(3-4):297-302. PubMed ID: 8535196
[TBL] [Abstract][Full Text] [Related]
39. Molecular analysis of immunoglobulin variable genes in human immunodeficiency virus-related non-Hodgkin's lymphoma reveals implications for disease pathogenesis and histogenesis.
Capello D; Martini M; Gloghini A; Cerri M; Rasi S; Deambrogi C; Rossi D; Spina M; Tirelli U; Larocca LM; Carbone A; Gaidano G
Haematologica; 2008 Aug; 93(8):1178-85. PubMed ID: 18556404
[TBL] [Abstract][Full Text] [Related]
40. [Molecular genetics of malignant non-Hodgkin's lymphoma].
Griesser H
Verh Dtsch Ges Pathol; 1992; 76():66-9. PubMed ID: 1283278
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
